IMC Chicago’s ARK Genomic Revolution ETF ARKG Stock Holding History

IMC Chicago’s Portfolio ARKG Stock Details ARKG Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$582K	Buy	+13,835	New	+$441K	﹤0.01%	4470
2025 Q4	–	Sell	-31,004	Closed	-$931K	–	4049
2025 Q3	$861K	Sell	31,004 -49,330	-61%	-$1.25M	﹤0.01%	2821
2025 Q2	$1.96M	Buy	80,334 +17,484	+28%	+$383K	﹤0.01%	2019
2025 Q1	$1.3M	Buy	62,850 +15,972	+34%	+$401K	﹤0.01%	2093
2024 Q4	$1.1M	Buy	+46,878	New	+$1.15M	﹤0.01%	2299
2024 Q2	–	Sell	-26,138	Closed	-$660K	–	2611
2024 Q1	$752K	Buy	26,138 +3,873	+17%	+$116K	﹤0.01%	1857
2023 Q4	$731K	Buy	+22,265	New	+$605K	﹤0.01%	1533
2023 Q1	–	Sell	-23,027	Closed	-$714K	–	1283
2022 Q4	$650K	Buy	+23,027	New	+$731K	﹤0.01%	1097
2021 Q2	–	Sell	-11,481	Closed	-$976K	–	1097
2021 Q1	$1.02M	Buy	+11,481	New	+$1.14M	﹤0.01%	852

Other funds holding ARKG

Citigroup New York $303B AUM 53.02% 1-Year Est. Return

LPL Financial San Diego, California $445B AUM 25.58% 1-Year Est. Return

MML Investors Services Springfield, Massachusetts $49B AUM 25.55% 1-Year Est. Return

NAM

NTV Asset Management Charleston, West Virginia $1.02B AUM 31.16% 1-Year Est. Return

SG Americas Securities New York $179B AUM 65.34% 1-Year Est. Return

MFPI

Midwest Financial Partners Investments St. Cloud, Minnesota $241M AUM

CIC

Canal Insurance Company Greenville, South Carolina $456M AUM 40.11% 1-Year Est. Return

HighTower Advisors Chicago, Illinois $103B AUM 28.65% 1-Year Est. Return

Cambridge Investment Research Advisors Fairfield, Iowa $44.6B AUM 28.94% 1-Year Est. Return

Commonwealth Equity Services Waltham, Massachusetts $79.5B AUM 27.1% 1-Year Est. Return

IMC Chicago's ARKG Position: Q2 2026 in Review

IMC Chicago opened a new position in ARK Genomic Revolution ETF (ARKG) in Q2 2026: 13,835 shares worth $582K. The stake represents ﹤0.01% of the portfolio and ranks #4470 among its holdings. This is a return to the name: IMC Chicago previously reported a position in ARKG as recently as Q3 2025.

IMC Chicago first reported a position in ARKG in Q1 2021 and has held it in 9 quarters since. The position peaked at $1.96M in Q2 2025. 157 funds tracked by Wall St. Rank hold ARKG as of Q2 2026.

IMC Chicago held 13,835 shares of ARK Genomic Revolution ETF worth $582K as of Q2 2026.
ARK Genomic Revolution ETF was a new IMC Chicago position in Q2 2026.
ARK Genomic Revolution ETF made up ﹤0.01% of IMC Chicago's portfolio in Q2 2026, its #4470 holding.
IMC Chicago first reported a position in ARK Genomic Revolution ETF in Q1 2021 and has held it in 9 quarters since.
IMC Chicago's ARK Genomic Revolution ETF position peaked at $1.96M in Q2 2025.
157 funds tracked by Wall St. Rank held ARK Genomic Revolution ETF as of Q2 2026.

Based on IMC Chicago's 13F filing for Q2 2026, filed 6 Aug 2026.